GEMPHIRE THERAPEUTICS INC's ticker is GEMP and the CUSIP is 36870A108. A total of 31 filers reported holding GEMPHIRE THERAPEUTICS INC in Q3 2018. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2018 | $10,614,000 | +56.5% | 1,041,635 | 0.0% | 0.78% | +55.4% |
Q1 2018 | $6,781,000 | +6.6% | 1,041,635 | +30.2% | 0.50% | -24.2% |
Q4 2017 | $6,360,000 | -15.8% | 800,000 | 0.0% | 0.67% | -50.0% |
Q3 2017 | $7,552,000 | -38.5% | 800,000 | -16.0% | 1.33% | -34.5% |
Q2 2017 | $12,282,000 | +22.8% | 952,798 | 0.0% | 2.04% | +40.1% |
Q1 2017 | $10,004,000 | +41.8% | 952,798 | +5.9% | 1.45% | +52.8% |
Q4 2016 | $7,056,000 | -28.2% | 900,000 | 0.0% | 0.95% | -12.3% |
Q3 2016 | $9,828,000 | – | 900,000 | – | 1.08% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Exchange Capital Management, Inc. | 758,623 | $7,966,000 | 2.88% |
Cormorant Asset Management, LP | 952,798 | $10,004,000 | 1.45% |
DAFNA Capital Management LLC | 52,797 | $554,000 | 0.47% |
HIGHLAND CAPITAL MANAGEMENT LP | 316,789 | $3,326,000 | 0.17% |
Cambridge Investment Research Advisors, Inc. | 150,564 | $1,581,000 | 0.03% |
NORRIS PERNE & FRENCH LLP/MI | 10,463 | $110,000 | 0.02% |
ADAGE CAPITAL PARTNERS GP, L.L.C. | 634,246 | $6,660,000 | 0.02% |
SEGALL BRYANT & HAMILL, LLC | 11,000 | $116,000 | 0.00% |
Acrospire Investment Management LLC | 400 | $4,000 | 0.00% |
Advisor Group, Inc. | 5,112 | $54,000 | 0.00% |